Share this video  

BTOG 2021 | Highlights from BTOG 2021

Alastair Greystoke • 23 Apr 2021
BTOG 2021

Alastair Greystoke, MBChB, MSc, PhD, MRCP, Northern Institute for Cancer Research, Newcastle University, Newcastle, UK, shares his highlights from the 19th British Thoracic Oncology Group (BTOG) Annual Conference 2021, commenting on the impacts of the COVID-19 pandemic.

Disclosures

Alastair Greystoke, MBChB, MSc, PhD, MRCP, has received consultancy and speaker fees from AstraZeneca, Amgen, Boehringer-Ingelheim, Bristol-Myers Squibb, Janssen/ J and J, Foundation Medicine, MSD, Novartis, Pfizer, Lilly, Takeda and Roche; and has received research funding from AstraZeneca.

More from Alastair Greystoke

2:24
BTOG 2018 speaker highlights
Alastair Greystoke et al. • 24 Jan 2018
10:58
Clinical frailty scale: predictor of prognosis for patients
Alastair Greystoke et al. • 19 Sep 2020
5:59
Deciphering an NGS report in lung cancer
Alastair Greystoke • 24 Jan 2022
4:53
Developments in personalized therapies for lung cancer
Alastair Greystoke • 24 Jan 2022

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals